When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in ...
Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.
A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results